-+ 0.00%
-+ 0.00%
-+ 0.00%

MEREO BIOPHARMA GROUP - CO AND SENTYNL TO COLLABORATE ON PHASE 3 STUDY DESIGN DURING OPTION PERIOD

Reuters·08/11/2026 12:00:03

Please log in to view news